Alteron's small molecules target the highly toxic TDP-43 protein to treat:

• ALS (Amyotrophic Lateral Sclerosis )
• AD (Alzheimer's Disease)
• FTD (Frontotemporal Dementia)
• CF (Cystic Fibrosis)